ArticleCancer medicine2026

Timing and Patterns of Relapse-Related Events Following Adjuvant CDK4/6 Inhibitors Combined With Endocrine Therapy in Patients With HR-Positive, HER2-Negative Early Breast Cancer.

Huihui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.